BREAST/ADJUVANT
A011202 Arsenault local IRB 50
(3) Randomized Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Pts Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemo
Clinical T1-3, N1, MO
Step 2 temporarily closed
BO41843 (D) Pruitt WIRB
Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of GDC-9545 Combined with Palbociclib Compared with Letrozole Combined with Palbociclib in Pts with ER+/HER2 Negative Locally Advanced or Metastatic Breast Cancer
S1706 (D) Pruitt CIRB
A Phase II Randomized Trial of Olaparib Administered Concurrently with Radiotherapy vs Radiotherapy Alone for Inflammatory Breast Cancer
S1418 D) Pruitt CIRB
(7) A Randomized Phase III Trial to Evaluate the Pruitt Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with ≥1cm Residual Invasive Cancer or Positive Lymph Nodes after Neoadjuvant Chemotherapy
A021502 (D) Ravipati CIRB
Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
NRG-GI004/1610 (D) Ravipati CIRB
Colorectal Cancer Metastatic dMMR
Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer
SWOG LungMap Ravipati CIRB
(8) Targeted Treatment for Advanced NSCLC
S1900B sub-study: (D) Ravipati CIRB
A Phase II Study of LOXO-292 in Patients with RET Fusion-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)
APL-101-01 (SPARTA) (D) Ravipati Advarra
Apollomics Inc. / Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
S1801 (D) Ravipati CIRB
A Phase II Randomized Study of Adjuvant vs Neoadjuvant MK-3475 (Pembrolizumab) for Clinically Detectable Stage III-IV High Risk Melanoma
EA3161 (D) Ravipati CIRB
A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA
NRG-HN005 (D) Ravipati CIRB
A Randomized Phase II/III Trial of De-intensified Radiation Therapy for Patients with Early-Stage, p16-Positive, Non-Smoking Associated Oropharyngeal Cancer
BlueStar Genomics Pruitt Advarra
iProcess Global Research Inc. / Collection & Distribution of Biofluids and Tumor Tissue Biospecimens for Research Purposes
CITY OF HOPE Ravipati local IRB 400
(11) Molecular Genetics Studies of Cancer Patients and Their Relatives
Revisions made
Closure: A011401
Temporary Closure:
New: BO41843, APL-101-01
Pending IRB:
Pending Activation:
-----------------------
Breast
TNBC
Colon
Lung-non small cell
Melanoma
Oropharyngeal
Tissue Banking
Genetics
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.